现代中药集团发盈警 预计2024年度净溢利下降至800万元至1200万元

智通财经网
Yesterday

智通财经APP讯,现代中药集团(01643)发布公告,预期集团将于截至2024年12月31日止年度取得金额介乎人民币800万元至1200万元的净溢利,而截至2023年12月31日止年度则取得约人民币4880万元的净溢利。净溢利有所下降乃主要归因于:于2024年2月至5月期间因制剂车间进行修缮工程引致的暂时停产及受国家新政策影响以及活跃客户数量下降导致收益减少;拆除制剂车间导致的物业、厂房及设备处置...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10